Skip to main content
. 2022 Jun 7;12:922418. doi: 10.3389/fonc.2022.922418

Table 5.

Categorical comparison of significant post-diagnosis weight loss incidence (in patients without cachexia at diagnosis) between prior medication use groups and anti-inflammatory medication null patients.

Prior medication use category (N) Patients that reached significant weight loss within 6 months of cancer diagnosis (%) P-value
No anti-inflammatory medication (1517) 638 (42.06%)
Medication groups
 Any glucocorticoid (228) 118 (51.75%) 0.0059
 Any NSAID (355) 185 (52.11%) 0.0006
 Low-dose aspirin (224) 113 (50.45%) 0.0180
 Other nonselective NSAIDs (115) 58 (50.43%) 0.0799
 Selective COX-2 inhibitors (91) 53 (58.24%) 0.0025

P values bolded if <0.05.